Use of the Concept of Equivalent Biologically Effective Dose (BED) to Quantify the Contribution of Hyperthermia to Local Tumor Control in Radiohyperthermia Cervical Cancer Trials, and Comparison With Radiochemotherapy Results

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 5, 2009, Pages 1538-1544

  Plataniotis, George A ^a   Dale, Roger G ^b  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Cervical cancer; Hyperthermia; Radiation equivalent; Radiotherapy

Indexed keywords

ONCOLOGY; RADIOTHERAPY;

BIOLOGICALLY EFFECTIVE DOSE; CERVICAL CANCER; COMBINED TREATMENTS; HYPERTHERMIA; LOCAL CONTROLS; LOCAL TUMOR CONTROLS; RADIATION-EQUIVALENT; RADIOCHEMOTHERAPY; RANDOMIZED CONTROLLED TRIALS; TUMOR CONTROL PROBABILITIES; TUMOR VOLUMES;

TUMORS;

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CELL KILLING; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HYPERTHERMIA; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOHYPERTHERMIA; RADIOSENSITIVITY; TUMOR LOCALIZATION; TUMOR VOLUME; UTERINE CERVIX CANCER;

ALGORITHMS; CELL DEATH; CELL PROLIFERATION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LINEAR MODELS; RADIATION TOLERANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RELATIVE BIOLOGICAL EFFECTIVENESS; UTERINE CERVICAL NEOPLASMS;

EID: 62649137722     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.11.034     Document Type: Article

References (45)

1. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systemic review and meta-analysis. Lancet 358 (2001) 781-786
2. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1161
3. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
4. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
5. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. J Clin Oncol 17 (1999) 1339-1348
6. Peters W.A., Liu P.Y., Barret R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
7. Pearcey R., Brundage M., Drouin P., et al. Phase III trial comparing radical radiotherapy with and without cisplatin in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 20 (2002) 966-972
8. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology Group Trial (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
9. Lorvidhaya V., Chitapanaraux I., Sangruchi S., et al. Concurrent mitomycin-C, 5-fluorouracil and radiotherapy in the treatment of locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 55 (2003) 1226-1232
10. Tseng C.J., Chang C.T., Lai C.H., et al. A randomised trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol 66 (1997) 52-58
11. Thomas G.M., Dembo A., Ackerman I., et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer. Gynecol Oncol 69 (1998) 137-145
12. Wong L.C., Choo Y.C., Choy D., et al. Long-term follow-up of potentiation of radiotherapy by cis-Platinum in advanced cervical cancer. Gynecol Oncol 35 (1989) 159-163
13. Franckena M., Stalpers L.J.A., Koper P.C.M., et al. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: An update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys 70 (2008) 1176-1182
14. Van der Zee J., Gonzalez Gonzalez D., van Rhoon G.C., et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective randomized, multicentre trial. Lancet 355 (2000) 1119-1125
15. Van der Zee J., and Gonzalez Gonzalez D. The Dutch Deep Hyperthermia Trial: Results in cervical cancer. Int J Hyperthermia 18 (2002) 1-12
16. Datta N.R., Bose A.K., and Kapoor H.K. Thermoradiotherapy in the management of carcinoma cervix (stage IIIB): A controlled clinical study. Indian Med Gaz 121 (1987) 68-71
17. Chen H.W., Jun-Jie F., and Wei L. A randomized trial of hyperthermo-radiochemotherapy for uterine cervix cancer. Chin J Clin Oncol 24 (1997) 249-251
18. Harima Y., Nagata K., Harima K., et al. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 17 (2001) 97-105
19. Sharma S., Patel F.D., Sandhu A.P., et al. A prospective randomized study of local hyperthermia as a supplement and radiosensitizer in the treatment of carcinoma of the cervix with radiotherapy. Endocuriether/Hyperthermia Oncol 5 (1989) 151-159
20. Vasanthan A., Mitsumori M., Park J.H., et al. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: A multi-institutional prospective randomized trial of the Atomic Energy Agency. Int J Radiat Oncol Biol Phys 61 (2005) 145-153
21. Van der Zee J., van Rhoon G.C., and Wust P. In regard to Dr. Vasanthan et al. Int J Radiat Oncol Biol Phys 61 (2005) 145-153
22. Field S.B. Biological aspects of hyperthermia. In: Field S.B., and Franconi C. (Eds). Physics and technology of hyperthermia (1987), Martinus Nijhoff, Dordrecht
23. Kampinga H.H., and Dikomey E. Hyperthermic radiosensitization: Mode of action and clinical relevance. Int J Radiat Biol 77 (2001) 399-408
24. Kirwan J.M., Symonds P., Green J.A., et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 68 (2003) 217-226
25. Jones E.L., Samulski T.V., Dewhirst M.W., et al. A pilot phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. Cancer 98 (2003) 277-282
26. Plataniotis G.A., and Dale R.G. Use of the concept of chemotherapy-equivalent biologically effective dose (BED) to provide quantitative evaluation of the contribution of chemotherapy to local tumor control in radio-chemotherapy cervical cancer trials. Int J Radiat Oncol Biol Phys 72 (2008) 1538-1543
27. Jones B., and Dale R.G. The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy. Br J Radiol 78 (2005) 939-944
28. Lim K., Chan P., Dinniwell R., et al. Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy: Radiobiologic modeling and correlation with tumor hypoxia. Int J Radiat Oncol Biol Phys 70 (2008) 126-133
29. Dale R.G., Coles I.P., Deehan C., et al. Calculation of integrated biological response in brachytherapy. Int J Radiat Oncol Biol Phys 38 (1997) 633-642
30. Fyles A., Milosevic M., Hedley D., et al. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 20 (2002) 680-687
31. Knocke T.H., Weitmann H.D., Feldmann H.J., et al. Intratumoral p02-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiother Oncol 53 (1999) 99-104
32. Rofstad E.K., Sundfor K., Lyng H., et al. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. Br J Cancer 83 (2000) 354-359
33. Hockel M., Schlenger K., Aral B., et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56 (1996) 4509-4515
34. Wust P., Hildebrandt B., Sreenivasa G., et al. Hyperthermia in combined treatment of cancer. Lancet Oncol 3 (2002) 487-497
35. Dewhirst M.W., Vujaskovic Z., Jones E., et al. Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia 21 (2005) 779-790
36. Dewhirst M.W., Phillips T.L., Samulski T.V., et al. RTOG quality assurance guidelines for clinical trials using hyperthermia. Int J Radiat Oncol Biol Phys 18 (1990) 1249-1259
37. Lukka H, Hirte H, Fyles A, et al. and members of the Gynecology Cancer Disease Site Group. Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-based Chemotherapy and Radiation. Practice Guideline Report #4-5. Program in evidence based care. A cancer care Ontario program. Available at http://www.CancerCare.on.ca/pdf/pebc4-5s.pdf. Accessed January 15, 2008.
38. Fowler J. Correction to Kasibhatla, et al. How much radiation is the chemotherapy worth in advanced head and neck cancer?. Int J Radiat Oncol Biol Phys 71 (2008) 326-329
39. Kasibhatla M., Kirkpatrick J.P., and Brizel D. How much radiation is the chemotherapy worth in advanced head and neck cancer?. Int J Radiat Oncol Biol Phys 68 (2008) 1491-1495
40. Kouloulias V., Plataniotis G.A., Kouvaris J., et al. Chemoradiotherapy combined with intracavitary hyperthermia for anal cancer. Feasibility and long-term results from a phase II randomized trial. Am J Clin Oncol 28 (2005) 91-99
41. Jones B., and Dale R.G. Radiobiological modeling and clinical trials. Int J Radiat Oncol Biol Phys 48 (2000) 259-265
42. Bentzen S.M. Design of clinical trials in radiation oncology: saving lives, not grays. In: Dale R., and Jones B. (Eds). radiobiological modelling in radiation oncology (2007), British Institute of Radiology, London 196-211
43. West C.M. Radiotherapy predictive assays. In: Dale R., and Jones B. (Eds). radiobiological modelling in radiation oncology (2007), British Institute of Radiology, London 35-50
44. West C.M., Davidson S.E., Roberts S.A., et al. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer 76 (1997) 1184-1190
45. Kagei K., Tokuuye K., Okumura T., et al. Long-term results of proton beam therapy for carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 55 (2003) 1265-1271